Compare FLEX & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLEX | WAT |
|---|---|---|
| Founded | 1990 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9B | 29.3B |
| IPO Year | 1997 | 1996 |
| Metric | FLEX | WAT |
|---|---|---|
| Price | $85.26 | $336.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 17 |
| Target Price | $66.89 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 2.9M | 765.4K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | 1.66 | ★ 10.76 |
| Revenue | ★ $28,679,925,000.00 | $3,165,286,000.00 |
| Revenue This Year | $8.14 | $104.66 |
| Revenue Next Year | $6.28 | $10.40 |
| P/E Ratio | $50.83 | ★ $31.09 |
| Revenue Growth | ★ 18.95 | 6.99 |
| 52 Week Low | $32.70 | $275.05 |
| 52 Week High | $84.56 | $414.15 |
| Indicator | FLEX | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 73.96 | 65.66 |
| Support Level | $60.15 | $282.76 |
| Resistance Level | N/A | $407.97 |
| Average True Range (ATR) | 2.74 | 9.55 |
| MACD | 1.32 | 3.69 |
| Stochastic Oscillator | 93.85 | 81.41 |
Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.